US Broker Ratings

Recursion Pharmaceuticals (RXRX) Investor Outlook: Exploring a 16.94% Potential Upside in the Biotech Sector

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company headquartered in Salt Lake City, Utah, is making waves in the healthcare sector with its innovative approach..

GeneDx Holdings Corp. (WGS): Investor Outlook Highlights Robust Revenue Growth and Positive Analyst Ratings

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, is capturing attention with its impressive revenue growth and strong analyst endorsements. With a..

Dynavax Technologies Corporation (DVAX): Investor Outlook Reveals 127.77% Potential Upside

Investors seeking opportunities in the healthcare sector might find Dynavax Technologies Corporation (NASDAQ: DVAX) an intriguing option. With a market capitalization of $1.17 billion, this biopharmaceutical..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Strong Buy Ratings Signal a Promising 14% Upside Potential

For investors eyeing opportunities within the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) stands out as a promising candidate, particularly in the burgeoning field of cell..

Enovis Corporation (ENOV) Stock Analysis: A Lucrative 67% Upside Potential in Medical Device Innovation

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, stands at an intriguing juncture for investors. With its focus on innovative medical device solutions,..

Vera Therapeutics, Inc. (VERA): Investor Outlook on a 109% Upside Potential in the Biotech Sector

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline focused on transformative treatments for serious..

Mesoblast Limited (MESO) Stock Analysis: A Biotech Titan with 92.94% Upside Potential

Mesoblast Limited (NASDAQ: MESO), a pioneering player in the biotechnology sector, is currently captivating the attention of investors with its innovative approach to regenerative medicine. With..

The Pennant Group, Inc. (PNTG): Potential Upside of 40% Ignites Investor Interest

The Pennant Group, Inc. (NASDAQ: PNTG) is capturing the attention of investors with its remarkable potential upside of 40.06%, as suggested by current analyst ratings. Operating..

Kestra Medical Technologies, Lt (KMTS) Stock Analysis: A 20% Upside Potential in the Healthcare Sector

Kestra Medical Technologies, Ltd (KMTS), a burgeoning player in the healthcare sector, has garnered significant attention from investors, particularly due to its promising growth potential and..

ANI Pharmaceuticals, Inc. (ANIP): Investor Outlook with 20% Potential Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a specialty and generic drug manufacturer, is drawing significant investor attention with its promising 20.33% potential upside. Headquartered in Baudette, Minnesota,..

10x Genomics, Inc. (TXG) Stock Analysis: Unpacking a 29% Potential Upside in the Healthcare Sector

Investors looking to capitalize on the innovative edge of the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing opportunity. This Pleasanton, California-based life..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Healthcare Innovator with 22.64% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is emerging as a strong contender in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Select Medical Holdings Corp (SEM) Stock Analysis: Strong Buy Ratings Signal 36% Upside Potential

Select Medical Holdings Corporation (NYSE: SEM), known for its extensive network of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics, has been making waves..

Certara, Inc. (CERT) Stock Analysis: Unveiling a 20% Upside Potential in Healthcare Innovation

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, is making waves in the health information services industry with its cutting-edge technology-enabled services and..

Tarsus Pharmaceuticals (TARS) Stock Analysis: A 9% Upside with Strong Buy Ratings

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is drawing significant attention in the biotechnology sector, particularly due to its innovative focus on eye care therapeutics. The Irvine, California-based..

NeoGenomics, Inc. (NEO) Stock Analysis: A Healthcare Diagnostics Player with a 7% Upside Potential

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the healthcare sector, operates a sophisticated network of cancer-focused testing laboratories across the United States and the United..

Healthcare Services Group, Inc. (HCSG): Investor Outlook on a Robust 15% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) is emerging as a crucial player within the healthcare sector, particularly in the specialized niche of medical care facilities. This..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring a 77% Potential Upside Amidst Clinical Advancements

Viridian Therapeutics, Inc. (NASDAQ: VRDN) stands as a promising player in the biotechnology sector, capturing the interest of investors with its focus on developing transformative treatments..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating the Challenges with an 18.39% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specifically within the medical devices industry, is currently navigating a challenging market environment...

89bio, Inc. (ETNB) Stock Analysis: Potential 97.97% Upside in the Biotech Arena

89bio, Inc. (NASDAQ: ETNB), a dynamic player in the biotechnology sector, is garnering significant attention from investors due to its promising potential upside and robust pipeline...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds